Poland-based DocPlanner has raked in €15 million in a Series D round of funding led by Enern Investments. The round saw participation from Target Global and Peak One Ventures. This round brings the total amount of funds raised by the firm to about €46 million.

The company plans to deploy the freshly raised capital to set up new offices in Brazil and Mexico over the next six months. It will also direct the funds in its core markets in Southern Europe and Latin America focusing primarily on marketing and sales.

Last year, DocPlanner had secured approximately €18 in Series C round, as it announced that it had merged with Spanish healthcare platform Doctoralia. It had also stated that is seeking more such possible acquisitions to further develop the platform’s SaaS capabilities. Mariusz Gralewski, founder and CEO of DocPlanner, in a statement, said,

We continue the process of integrating the DocPlanner and Doctoralia teams and have already developed a very coherent and well-functioning organisation with a common mission and strategy. We have been able to take the best practices and capabilities from each business to create something that is way beyond the sum of its parts.

DocPlanner is an online appointment booking marketplace that serves both consumers and doctors. It has a marketplace for users who can look up for doctors and book an appointment, while its cloud software serves healthcare providers well. Doctors, dentists, dietitians, can accept bookings online and manage their professional profiles.

The company, that serves 24 countries, has stated that most of the users are based in southern Europe. Also, its website claims to have 340,000 bookings per month, and that 20 million patients signed up to its platform. Mariusz added,

In addition to consolidating our presence in core markets, our goal with the new funding is to expand our offering to doctors by moving beyond the calendar management. This will also help us accomplish our global mission to ‘make the healthcare experience more human’.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.